InMode (INMD) Change in Accured Expenses (2018 - 2025)

InMode (INMD) posted quarterly Change in Accured Expenses of $4.8 million for Q4 2025, up 212.16% year-on-year from $1.5 million in Q4 2024, and up 743.79% on a QoQ basis from $564000.0 in Q3 2025.

InMode (INMD) Change in Accured Expenses (2018 - 2025) Analysis & Trends

InMode (INMD) has reported Change in Accured Expenses for 8 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.

  • Quarterly Change in Accured Expenses rose 212.16% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 12.83% YoY) and the FY2025 annual result came in at $2.2 million, up 12.83% from the prior year.
  • Change in Accured Expenses advanced to $4.8 million in Q4 2025 per INMD's latest filing, from $564000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for INMD reached as high as $14.6 million in Q4 2022 and fell as low as -$23.0 million in Q1 2023.
  • A 5-year average of $1.2 million and a median of $1.4 million in 2024 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 808.9% — and 2024, when it plunged 2179.9%.
  • Year by year, Change in Accured Expenses stood at -$2.1 million in 2021, then surged by 808.9% to $14.6 million in 2022, then plunged by 98.6% to $204000.0 in 2023, then tumbled by 2179.9% to -$4.2 million in 2024, then soared by 212.16% to $4.8 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $4.8 million, $564000.0, and $127000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -654.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -347.10 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 145.10 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -250.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 21.07 Mn
10 InMode 981,130.50 -479.15 Mn 61.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.76 Mn
Dec 31, 2025 4.76 Mn
Sep 30, 2025 564,000.00
Sep 30, 2025 564,000.00
Jun 30, 2025 127,000.00
Jun 30, 2025 127,000.00
Mar 31, 2025 -3.29 Mn
Mar 31, 2025 -3.29 Mn
Dec 31, 2024 -4.24 Mn
Dec 31, 2024 -4.24 Mn
Sep 30, 2024 11.72 Mn
Sep 30, 2024 11.72 Mn
Jun 30, 2024 2.24 Mn
Jun 30, 2024 2.24 Mn
Mar 31, 2024 -7.80 Mn
Mar 31, 2024 -7.80 Mn
Dec 31, 2023 204,000.00
Dec 31, 2023 204,000.00
Sep 30, 2023 3.04 Mn
Sep 30, 2023 3.04 Mn